Theoretical morphological approach to simple peritoneal sclerosis

International Journal of Artificial Organs

Volumn 28, Issue 2, 2005, Pages 85-89

  Di Paolo, N ^a   Gaggiotti, E ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Peritoneal dialysis; Peritoneal dialysis solution; Peritoneal sclerosis; Simple peritoneal sclerosis

Indexed keywords

MORPHOLOGICAL APPROACH; MORPHOLOGICAL STUDY; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS SOLUTION; PERITONEAL SCLEROSE; SIMPLE PERITONEAL SCLEROSE; SIMPLE++;

CYTOKERATIN; FIBRONECTIN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PERITONEAL DIALYSIS FLUID; TRANSFORMING GROWTH FACTOR BETA;

BASEMENT MEMBRANE; BIOCHEMISTRY; BIOCOMPATIBILITY; CELL DAMAGE; CYTOKINE RELEASE; DISEASE ASSOCIATION; EDITORIAL; FIBROSIS; HUMAN; IMMUNOLOGY; MESOTHELIUM CELL; MORPHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEUM; SCLEROSIS; THEORETICAL STUDY; UREMIA; WOUND HEALING IMPAIRMENT;

EID: 16844385687     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880502800202     Document Type: Editorial

References (25)

1. Di Paolo N, Garosi G. Peritoneal sclerosis. J Nephrol 1999; 12: 347-61.
2. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. Perit Dial Int 2000; 20 (suppl 4): S43-55.
3. Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; (suppl 3): S20.
4. Garosi G, Di Paolo N. Peritoneal sclerosis: One of two nosological entities? Semin Dial 2000; 13: 297-308.
5. Mortier S, Faict D, Schalkwijk CG, Lamiere NH, De Vriese AS. Long term exposure to new peritoneal dialysis solutions: Effect on the peritoneal membrane. Kidney Int 2004; 66: 1257-65.
6. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, MacKenzie RK, Williams GT. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-9.
7. Selgas R, Fernanzed-Reyes MJ, Bosque E, Bajo MA, Borrego F, Jimenez C, Del Peso G, De Alvaro F. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23: 64-73.
8. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): An in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9: 41-5.
9. Gotloib L, Barsella P, Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum. Perit Dial Bull 1985; 5: 212-5.
10. Di Paolo N, Garosi G, Traversari L, et al. Mesothelial biocompatibility of peritoneal dialysis solution. Perit Dial Int 1993; 13 (suppl): S109-12.
11. Gotloib L, Wajsbrot V, Shostak A. Ecology of the peritoneum: A substantial role for the osmotic agents resulting in apoptosis of mesothelial cells. Contrib Nephrol 2003; 140: 10-17.
12. Garosi G, Di Paolo N. Inflammation and gross vascular alterations are characteristic histological features of sclerosing peritonitis, Perit Dial Int 2001; 21: 417-20.
13. Di Paolo N, Sacchi G. Anatomy and physiology of the peritoneal membrane. Contrib Nephrol 1990; 84: 10-26.
14. Naiki Y, Maeda Y, Matsuo K, Yonekawa S, Sakaguchi M, Iwamoto I, Hasegawa H, Kanamaru A. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis. J Nephrol 2003; 16: 95-102.
15. Ogata S, Yorioka N, Kiribayashi K, Naito T, Kuratsune M, Nishida Y. Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid. Adv Perit Dial 2003; 19: 2-5.
16. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 2003; 14: 2109-18.
17. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-13.
18. Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002; 22: 171-7.
19. Gillerot G, Devuyst O. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis. Clin Nephrol 2003; 60: 1-6.
20. Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS. Long term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 2004; 66: 1257-65.
21. Musi B, Braide M, Carlsson O, Wieslander A, Albrektsson A, Ketteler M, Westenfeld R, Floege J, Rippe B. Biocompatibility of peritoneal dialysis fluids: Long-term exposure of nonuremic rats. Perit Dial Int 2004; 24: 37-47.
22. Tamura M, Osajima A, Nakayamada S, Anai H, Kabashima N, Kanegae K, Ota T, Tanaka Y, Nakashima Y. High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells. Kidney Int 2003; 63: 722-31.
23. Lee SK, Kim BS, Yang WS, Kim SB, Park SK, Park JS. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64.
24. Plum J, Hermann S, Fussholler A, Schoenicke G, Donner A, Rohrborn A, Grabensee B. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 2001; 78 (suppl): S42-7.
25. Devuyst O, Topley N, Williams JD. Morphological and functional changes in the dialysed peritoneal cavity: Impact of more biocompatible solutions. Nephrol Dial Transplant 2002; 17 (suppl 3): S12-5.